Understanding Clinical Papers 4e
Language: English
Published by Wiley-Blackwell, 2021
- Softcover
- New

Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
AbeBooks seller since January 6, 2003
Condition: New
US$ 75.14
Quantity: 2 available
Add to basketItem description from seller
4th edition. 288 pages. 9.50x7.75x0.75 inches. In Stock.
Seller Inventory # __1119573165
- Title
- Understanding Clinical Papers 4e
- Author
- Bowers, David/ House, Allan/ Owens, David/ Bewick, Bridgette
- Publisher
- Wiley-Blackwell
- Publication year
- 2021
- Condition
- Brand New
- Binding
- Paperback
- Language
- English
- ISBN 10
- 1119573165
- ISBN 13
- 9781119573166
- Edition
- 4th Edition
- Item weight
- 0.65 kilograms
For two decades, Understanding Clinical Papers has been helping students and professionals understand the research that supports evidence-based practice. Now in its fourth edition, this popular introductory textbook covers every major aspect of reading and evaluating clinical research literature, from identifying the aims and objectives of a paper to analysing the data with different multivariable methods. Numerous excerpts from actual clinical research papers make learning real and immediate, supported by a unique visual approach that reinforces key points and connects examples with the chapter material.
The fourth edition includes extensively revised content throughout, including four brand-new chapters covering qualitative studies, Poisson regression, studies of complex interventions, and research using previously collected data. New and updated material discusses the difference between clinical and statistical significance, the consequences of multiple testing and methods of correction, how topic guides are used to explore and explain participants' experiences, standardised guidelines for writing trials and reviews, and much more. Offering clear explanations of important research-related topics, this reader-friendly resource:
- Offers a clear, concise, and accessible approach to learning how to read and analyse clinical research literature
- Features new coverage of qualitative research, including descriptive studies, sampling and populations, and identifying, summarising, and measuring qualitative characteristics
- Provides new material on missing data, sub-group analysis, feasibility and pilot studies, cluster randomised trials, and adaptive trial designs
- Includes new tables, abstracts, and excerpts from recent clinical research literature
Understanding Clinical Papers is essential reading for all healthcare professionals and students, particularly those involved in clinical work and medical research, as well as general readers wanting to improve their understanding of research literature.
"Synopsis" may belong to another edition of this title.
About the Author
DAVID BOWERS, Medical Statistician, University of Leeds Medical School, UK.
ALLAN HOUSE, Professor, Director of Leeds Institute of Health Science, University of Leeds, UK.
DAVID OWENS, Senior Lecturer in Psychiatry, Leeds Institute of Health Science, University of Leeds, UK.
BRIDGETTE BEWICK, Senior Lecturer in Health Research, Leeds Institute of Health Sciences, University of Leeds, UK.
"About the title" may belong to another edition of this title.
Revaluation Books
Exeter, United Kingdom
AbeBooks seller since January 6, 2003
Shipping rates from United Kingdom to U.S.A.
| Item | 7 to 14 business days | 2 to 3 business days |
|---|---|---|
| First item | US$ 16.89 | US$ 33.78 |
Payment methods
Seller's business information
Edward Bowditch Ltd
Exstowe, Exton
Exeter, United Kingdom EX3 0PP
Terms of sale
Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch
Shipping terms
Orders usually dispatched within two working days. Please note that at this time all domestic United Kingdom orders are sent by trackable UPS courier, we choose not to offer a lower cost alternative.